查看完整行情页>>

|

货币单位:美元(USD)

辉瑞制药公司

Pfizer Inc. (pfe)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
William C. Sessa Currently, William C. Sessa occupies the position of SVP &Chief Scientific Officer-Internal Medicine at Pfizer Inc.
Maria Rivas Currently, Maria Rivas is Chief Medical Affairs Officer at Pfizer Inc. Dr. Rivas is also on the board of The Cooper Cos., Inc., New Jersey Performing Arts Center Corp. and 50. In the past she held the position of Senior Vice President-Global Medical Affairs at Merck & Co., Inc., Senior VP & Head-Global Medical Affairs at Merck KGaA and Chief Medical Officer & Senior Vice President of EMD Serono, Inc. (a subsidiary of Merck KGaA), Vice President-Global Medical Affairs at AbbVie, Inc., Head-Women's Health Medical Affairs at Eli Lilly & Co., Vice President at Oncology, Inc. and Vice President-US General Medicine at Bayer HealthCare. Dr. Rivas received an undergraduate degree from Brandeis University and a doctorate from Columbia University College of Physicians & Surgeons.
Jennifer B. Damico Jennifer B. Damico is Senior Vice President & Controller at Pfizer Inc. Ms. Damico received an MBA from Pace University.
Albert Bourla Albert Bourla is a businessperson who has been the head of 6 different companies. Dr. Bourla is on the board of Biotechnology Innovation Organization, Catalyst, Inc., Healthcare Leadership Council and United States Council for International Business and Chairman & Chief Executive Officer for Pfizer Inc., Co-Chairman of The Partnership for New York City, Inc., Chairman-Elect at Pharmaceutical Research & Manufacturers of America, President at International Federation of Pharmaceutical Manufacturers, Member of Council on Foreign Relations, Inc., Member of The Business Roundtable and Member of The Business Council. Albert Bourla received a doctorate from School of Veterinary Medicine (Greece).
Rady A. Johnson Rady A. Johnson is EVP, Chief Compliance, Quality & Risk Officer at Pfizer Inc. Mr. Johnson is also on the board of Pro Bono Partnership, Inc. and Citizens Crime Commission of New York City. In his past career Mr. Johnson was Senior Auditor at Arthur Anderson & Co. and Member of Hogan & Hartson LLP. He received an undergraduate degree from the University of Richmond and a graduate degree from Georgetown University Law Center.
Chris Boshoff Chris Boshoff is Chief Oncology Officer & Executive Vice President at Pfizer Inc. and Vice President-Translational Oncology at Pfizer (La Jolla). He received a doctorate from the University of Pretoria.
Aida Habtezion Aida Habtezion occupies the position of Chief Medical Officer & Head-Worldwide Medical at Pfizer Inc. He is also on the board of PhRMA Foundation, American Pancreatic Association Inc. and International Science Reserve and Member-Governors Board at New York Academy of Sciences, Member of Association of American Physicians and Member of American Society for Clinical Investigation. In the past he was Associate Dean-Academic Affairs at Stanford University School of Medicine. He received an undergraduate degree from the University of Alberta, a graduate degree from the University of Guelph and a doctorate from McMaster University.
Luis Jodar Presently, Luis Jodar is Chief Medical Officer-Vaccines & Senior VP at Pfizer Inc.
Annaliesa Anderson Presently, Annaliesa Anderson occupies the position of SVP, Head-Vaccine Research & Development at Pfizer Inc. Dr. Anderson received a doctorate from the University of Warwick.
Jeff Settleman Presently, Jeff Settleman is Co-Chief Scientific Officer at Pfizer Inc. and Member-Scientific Advisory Board at Trillium Therapeutics ULC (a subsidiary of Pfizer Inc.). Dr. Settleman is also Member-Scientific Advisory Board at Trillium Therapeutics ULC. In his past career he was Director-Scientific & Molecular Therapeutics at Massachusetts General Hospital Cancer Center, Head-Oncology Research at Calico LLC and Professor at Harvard Medical School. He received an undergraduate degree from the University of Pennsylvania and a doctorate from Yale University.
Michael McDermott Michael McDermott is Chief Global Supply Officer & Executive VP at Pfizer Inc. In his past career Mr. McDermott held the position of Vice President-Site Operations at Wyeth Holdings LLC. He received an undergraduate degree and a graduate degree from New Jersey Institute of Technology.
Alexandre de Germay Alexandre de Germay is Co-Chief Executive Officer at Laboratoires Majorelle SAS. He is also Chief International Commercial Officer & EVP at Pfizer Inc. He previously occupied the position of Senior Vice President & Global Head-Cardiovascular at Sanofi.
Aamir Malik Aamir Malik is Chief Commercial Officer-US & Executive VP at Pfizer Inc. In his past career Mr. Malik was Managing Partner at McKinsey & Co., Inc. and Member-Dean's Council at Kelley School of Business. Mr. Malik received an undergraduate degree from Indiana University.
Patrice Ettinger Patrice Ettinger is on the board of International Association of Privacy Professionals (former Chairman) and Chief Privacy Offucer at Pfizer Inc.
Payal Sahni Becher Payal Sahni Becher is Chief People Experience Officer & Executive VP at Pfizer Inc. She received an undergraduate degree from Rider University and a graduate degree from Fairleigh Dickinson University.
Lidia L. Fonseca Lidia L. Fonseca holds the position of Executive VP, Chief Technology & Digital Officer at Pfizer Inc. and Advisor at Pegasus Tech Ventures, Inc. She is also on the board of The U.S.-Japan Business Council, Inc., Medtronic Plc and Q Squared Solutions Holdings Ltd. She previously occupied the position of Chief Information Officer & Senior Vice President of Laboratory Corp. of America Holdings, Chief Information Officer & Senior Vice President at Quest Diagnostics, Inc., Vice President-Supply Chain Management at Nuclear Medicine Professionals, Inc., Founding Member at Synaptic Health Alliance, Executive VP-Global Operations & Technology at Synexus Compass, Inc. and Chief Information Officer for Philips Medical Systems. Lidia L. Fonseca received an undergraduate degree from the University of California, Berkeley and an MBA from Rotterdam School of Management.
Mikael Dolsten Currently, Mikael Dolsten is Co-Chief Scientific Officer & President-Research at Pfizer Inc. He is also Member-Overseers Board at The Scripps Research Institute, Member of Royal Swedish Academy of Engineering Sciences and Member of Government-University-Industry Research Roundtable and on the board of 5 other companies. In the past he was Global Vice President at AstraZeneca PLC, Principal at OrbiMed Advisors LLC and Partner at OrbiMed Advisors Private Equity (a subsidiary of OrbiMed Advisors LLC), President at Wyeth Research, Executive VP & Head-Worldwide Research at Boehringer Ingelheim Pharmaceuticals, Inc., Senior Vice President for Wyeth LLC and Senior Vice President at Wyeth Pharmaceuticals LLC. Mikael Dolsten received a doctorate from the University of Lund.
Douglas M. Lankler Currently, Douglas M. Lankler holds the position of Executive Vice President & General Counsel at Pfizer Inc. and EVP, Chief Compliance & Risk Officer at Wyeth LLC (a subsidiary of Pfizer Inc.). In his past career he was Assistant Attorney at US Department of Justice. Mr. Lankler received an undergraduate degree from The State University of New York and a graduate degree from Cornell Law School.
David M. Denton Currently, David M. Denton is Chief Financial Officer & Executive Vice President at Pfizer Inc. Mr. Denton is also on the board of Haleon Plc. In the past Mr. Denton occupied the position of Chief Financial Officer & Executive Vice President of Lowe's Companies, Inc. and Chief Financial Officer & Executive Vice President at CVS Health Corp. Chief Financial Officer & Executive Vice President at CVS Pharmacy, Inc. and Chief Financial Officer & Controller at Caremark PhC LLC (both are subsidiaries of CVS Health Corp.). Mr. Denton received an undergraduate degree from Kansas State University and an MBA from The Wake Forest University School of Business.
Sally Susman Sally Susman occupies the position of Chief Corporate Affairs Officer & Executive VP at Pfizer Inc. She is also Co-Chairman at International Rescue Committee, Inc., Member of Council on Foreign Relations, Inc. and Commissioner of New York City Commission on State Parks and on the board of 10 other companies. In her past career Sally Susman held the position of Executive Vice President-Global Communications at The Estée Lauder Companies, Inc., Deputy Assistant Secretary at US Department of Commerce (District of columbia), Director-International Council at US Department of State (District of columbia) and Legislative Assistant at US Senate Committee on Commerce, Science & Transportation. Sally Susman received an undergraduate degree from Connecticut College.
Christopher J. Stevo Christopher J. Stevo occupies the position of Chief Investor Relations Officer & Senior VP at Pfizer Inc. In his past career Mr. Stevo occupied the position of Analyst at Enron Corp., Senior Vice President & Portfolio Manager at Putnam Investment Management LLC, Vice President & Senior Equity Analyst at Amundi Asset Management US, Inc. and Head-Investor Relations1 at Alexion Pharmaceuticals, Inc. Mr. Stevo received an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from The University of Chicago Booth School of Business.
Andy Schmeltz Andy Schmeltz is Senior VP-Commercial Strategy & Innovation at Pfizer Inc.
Suneet Varma Suneet Varma is on the board of Drew University, Kent Place School, Inc., Cerevel Therapeutics Holdings, Inc. and Cerevel Therapeutics, Inc. and President-US Oncology Business Unit at Pfizer Inc. In the past Mr. Varma was President & General Manager at Pfizer Consumer Healthcare (United Kingdom). He received an MBA from Harvard Business School and an undergraduate degree from Tufts University.
Susan D. Desmond-Hellmann Susan D. Desmond-Hellmann holds the position of Advisor at GV Management Co. LLC. She is also on the board of Pfizer Inc., Bill & Melinda Gates Medical Research Institute, Gates Medical Research Institute and National Resilience, Inc. In the past she was Senior Advisor at BDT Capital LLC, President-Product Development at Genentech, Inc., Associate Director-Clinical Cancer Research at Bristol-Myers Squibb Pharmaceutical Research Institute, Chief Executive Officer for Bill & Melinda Gates Foundation Trust and Chancellor at The University of California, San Francisco. Susan D. Desmond-Hellmann received an undergraduate degree and a doctorate from the University of Nevada and a graduate degree from the University of California, Berkeley.
Helen H. Hobbs Currently, Helen H. Hobbs occupies the position of Science Partner at The Column Group LLC. Dr. Hobbs is also on the board of Pfizer Inc. and Atavistik Bio, Inc. and Member of Association of American Physicians, Member of American Society of Clinical Investigation and Professor & Director-McDermott Center at The University of Texas Southwestern Medical Center. She received an undergraduate degree from Stanford University and a doctorate from Case Western Reserve University.
James Quincey James Quincey is Chairman & Chief Executive Officer at The Coca-Cola Co. and Member of The Business Roundtable and on the board of 6 other companies. In his past career Mr. Quincey held the position of Co-Chairman of The Consumer Goods Forum and Partner-Strategy Consulting at Kalchas Group. He received an undergraduate degree from The University of Liverpool.
Joseph J. Echevarria Joseph J. Echevarria is a businessperson who has been at the head of 5 different companies and occupies the position of Non-Executive Chairman of The Bank of New York Mellon Corp. and Chief Executive Officer for University of Miami Health System. He is also on the board of Pfizer Inc., Unum Group, Xerox (Nederland) BV and My Brother'S Keeper Alliance (former Chairman) and Chief Executive Officer at the University of Miami. Mr. Echevarria previously held the position of Chief Executive Officer at Deloitte LLP (New York), Member of President's Export Council and Member of US Election Assistance Commission. Mr. Echevarria received an undergraduate degree from the University of Miami.
Dan R. Littman Founder of Vedanta Biosciences, Inc., Immunai, Inc. and Orca Pharmaceuticals Ltd., Dan R. Littman is an entrepreneur who presently holds the position of Venture Partner at Catalio Capital Management LP, Scientific Advisory Board at ChemoCentryx, Inc., Co-Scientific Founder at Vedanta Biosciences, Inc. and Scientific Co-Founder at Immunai, Inc. Dr. Littman is also on the board of Pfizer Inc. and Member of National Academy of Sciences, Member of National Academy of Medicine (United States) and Professor at NYU Langone Medical Center. In his past career Dr. Littman was Professor-Microbiology & Immunology at the University of California. Dan R. Littman received an undergraduate degree from Princeton University and a doctorate from Washington University School of Medicine.
James C. Smith Currently, James C. Smith is President & Chief Executive Officer for Refinitiv Transaction Services Ltd. He is also Chairman for Thomson Reuters Foundation and Member-International Business Council at The World Economic Forum USA, Inc. and on the board of 5 other companies. In his past career Mr. Smith was President & Non-Independent Director at Thomson Reuters Corp., Chief Operating Officer of Thomson Corp., Head-Operations for Thomson Newspapers Ltd., President & CEO-Academic & Reference Group at Cengage Learning, Inc. and Member-International Business Council at Forum Mondial de L'Economie. Mr. Smith received an undergraduate degree from Marshall University.
Susan J. Hockfield Presently, Susan J. Hockfield holds the position of Co-Chairman at Advanced Manufacturing Partnership Steering Committee. She is also President-Emeritus & Professor at Massachusetts Institute of Technology, Member of American Academy of Arts & Sciences, Member of American Association for the Advancement of Science, Member of Society For Neuroscience, Member of Myanmar International Trading Corp and Member of MIT Corp. (United States) and on the board of 8 other companies. In her past career Dr. Hockfield held the position of Trustee at Carnegie Corp. of New York, Dean at Yale University and Trustee at Woods Hole Oceanographic Institution. Dr. Hockfield received an undergraduate degree from Rochester Christian University and a doctorate from Georgetown University School of Medicine.
Scott Gottlieb Presently, Scott Gottlieb holds the position of Special Partner at NEA Management Co. LLC. Dr. Gottlieb is also Member of National Academy of Medicine (United States) and on the board of 6 other companies. He previously held the position of Managing Director at T.R. Winston & Co., Inc., Deputy Commissioner-Medical & Scientific Affairs at US Food & Drug Administration, Commissioner for US Food & Drug Administration, Analyst at Alex. Brown & Sons, Inc. and Senior Adviser to the Administrator at Centers for Medicare & Medicaid Services (US). Scott Gottlieb received a doctorate from Icahn School of Medicine at Mount Sinai and an undergraduate degree from Wesleyan University.
Ronald Edward Blaylock Ronald Edward Blaylock founded GenNx360 Management Company LLC. Presently, Mr. Blaylock holds the position of Chairman of Miller Environmental Group, Inc., Chairman of ITsavvy LLC and Managing Partner at GenNx360 Management Company LLC. Mr. Blaylock is also Member-Overseers Board at The Leonard N Stern School of Business and on the board of 12 other companies. He previously held the position of Chairman & Chief Executive Officer of Blaylock & Co, Inc., Principal at UBS Americas, Inc., Principal at Citigroup Global Markets, Inc. (Broker) and Principal at PaineWebber, Inc. Ronald Edward Blaylock received an undergraduate degree from Georgetown University and an MBA from The Leonard N Stern School of Business.
Shantanu Narayen Shantanu Narayen founded Pictra, Inc. Mr. Narayen is Chairman & Chief Executive Officer at Adobe, Inc. He is also on the board of Pfizer Inc., Adobe Systems Software Ireland Ltd. and US India Strategic Partnership Forum and Chairman of Adobe Foundation. Shantanu Narayen previously was Principal at Apple, Inc. and Director-Desktop & Collaboration Products at Silicon Graphics, Inc. He received a graduate degree from Bowling Green State University, an undergraduate degree from Osmania University and an MBA from Haas School of Business.
Suzanne Nora Johnson Suzanne Nora Johnson is a businessperson who has been at the head of 5 different companies. Ms. Johnson holds the position of Chairman at Intuit, Inc. Ms. Johnson is also Co-Chairman-Trustees Board at The Brookings Institution, Chairman at The John & Mary R. Markle Foundation, Inc., Member of American Academy of Arts & Sciences, Member of The World Economic Forum USA, Inc., Member of Global Agenda Council and Treasurer & Director at TechnoServe, Inc. and on the board of 5 other companies. She previously occupied the position of Chairman of Global Markets Institute and Trustee at Carnegie Institution of Washington. Ms. Johnson received an undergraduate degree from the University of Southern California and a graduate degree from Harvard Law School.